Trial intelligence / Profile preview

DX02 vs miconazole for vulvovaginal candidiasis

CTR20150516Phase 2Active

Sponsor
Hubei Dongxin Pharmaceutical
Start
Aug 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of clotrimazole in vulvovaginal candidiasis (VVC), sponsored by Hubei Dongxin Pharmaceutical. Started Aug 2015; status: active.

02

Drugs

clotrimazole
03

Conditions

vulvovaginal candidiasis (VVC)

Beyond the preview

Go deeper on CTR20150516.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150516.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call